Publicaciones en las que colabora con Rafael Marcos Gragera (26)

2024

  1. Differences in survival and recurrence of colorectal cancer by stage across population-based European registries

    International Journal of Cancer, Vol. 155, Núm. 5, pp. 807-815

2021

  1. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

    Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645

  2. Study protocol on Socioeconomic and Geographic Inequalities in Cancer Incidence, Mortality and Survival in Spain: Multilevel Population-Base Study: DESOCANES study

    Gaceta Sanitaria, Vol. 35, Núm. 2, pp. 199-203

2020

  1. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study

    European Journal of Surgical Oncology, Vol. 46, Núm. 6, pp. 1151-1159

2018

  1. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 201-211

  2. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years

    Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1289-1301

2017

  1. Data quality in rare cancers registraton: The report of the RARECARE data quality study

    Tumori, Vol. 103, Núm. 1, pp. 22-32

  2. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  3. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  4. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413

  5. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404

  6. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

    The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217

2015

  1. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    The Lancet, Vol. 385, Núm. 9972, pp. 977-1010

  2. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2130-2143

2014

  1. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

    Cancer Epidemiology, Vol. 38, Núm. 6, pp. 670-678

2012

  1. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe

    European Journal of Cancer, Vol. 48, Núm. 2, pp. 159-169

  2. Carcinoma of endocrine organs: Results of the RARECARE project

    European Journal of Cancer, Vol. 48, Núm. 13, pp. 1923-1931

  3. Embryonal cancers in Europe

    European Journal of Cancer, Vol. 48, Núm. 10, pp. 1425-1433

  4. Epidemiology of glial and non-glial brain tumours in Europe

    European Journal of Cancer, Vol. 48, Núm. 10, pp. 1532-1542

  5. Incidence and survival of rare urogenital cancers in Europe

    European Journal of Cancer, Vol. 48, Núm. 4, pp. 456-464